معرفی
Ryan Nelson is a research scientist at Newcastle University specializing in prostate cancer immunology and molecular oncology. His work focuses on the mechanistic role of glycosylation enzymes like ST3Gal1 in tumor immunity and advanced in vitro cancer modeling.
Research interests span Cancer Research, Immunology, Molecular Biology, Prostate Cancer, Tumor Immunology, and In Vitro Modeling. His laboratory investigates how sialyltransferase-mediated glycan modifications regulate immune checkpoint interactions through Siglec receptors, with implications for immunotherapy development. Recent work emphasizes engineering physiologically relevant prostate cancer microenvironments for therapeutic screening.
Current research demonstrates significant contributions to understanding ST3Gal1-Siglec axis in anti-tumor immunity (2023-2024) and developing novel in vitro prostate cancer platforms. Collaborations include oncology, glycobiology, and tissue engineering specialists across multiple departments at Newcastle University.
